Lactoferrin: A biologically active molecule for bone regeneration

Current Medicinal Chemistry

Volumn 18, Issue 8, 2011, Pages 1220-1229

  Amini, A A ^a   Nair, L S ^a,b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Angiogenesis; Bone regeneration; Immunoregulation; Lactoferrin

Indexed keywords

BIOMATERIAL; CISPLATIN; COLLAGEN TYPE 1; COLONY STIMULATING FACTOR 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; IRON; IRON BINDING PROTEIN; LACTOFERRICIN B; LACTOFERRIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TALACTOFERRIN; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR OSTERIX; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE DENSITY; BONE GROWTH; BONE REGENERATION; BONE REMODELING; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TYPE; COLOSTRUM; CYTOKINE PRODUCTION; DIABETIC FOOT; DIET SUPPLEMENTATION; EXOCRINE GLAND; HUMAN; IMMUNOMODULATION; INFECTION RESISTANCE; INNATE IMMUNITY; IRON TRANSPORT; KIDNEY CARCINOMA; LUNG NON SMALL CELL CANCER; MILK; MUSCLE REGENERATION; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPOROSIS; PERIODONTITIS; PLEIOTROPY; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; TISSUE ENGINEERING;

ANIMALS; BONE REGENERATION; HUMANS; LACTOFERRIN; OSTEOBLASTS;

EID: 79952784789     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986711795029744     Document Type: Article

References (141)

1. González-Chávez, S. A.; Arévalo-Gallegos, S.; Rascón-Cruz, Q. Lactoferrin: Structure, function and applications. Int. J. Antimicrob. Agents, 2009, 33(4), 301.e1-8.
2. Baker, E. N.; Baker, H. M. A structural framework for understanding the multifunctional character of lactoferrin. Biochimie, 2009, 91(1), 3-10.
3. van der Strate, B. W.; Beljaars, L.; Molema, G.; Harmsen, M. C.; Meijer, D. K. Antiviral activities of lactoferrin. Antiviral Res., 2001, 52(3), 225-39. (Pubitemid 33000113)
4. Anderson, B. F.; Baker, H. M.; Dodson, E. J.; Norris, G. E.; Rumball, S. V.; Waters, J. M.; Baker, E. N. Structure of human lactoferrin at 3.2-A resolution. Proc. Natl. Acad. Sci. U.S.A., 1987, 84(7), 1769-73. (Pubitemid 17054094)
5. Harrington, J. P. Spectroscopic analysis of the unfolding of transition metalion complexes of human lactoferrin and transferrin. Int. J. Biochem., 1992, 24(2), 275-80.
6. Anderson, B. F.; Baker, H. M.; Norris, G. E.; Rice, D. W.; Baker, E. N. Structure of human lactoferrin: Crystallographic structure analysis and refinement at 2.8 A resolution. J. Mol. Biol., 1989, 209(4), 711-34. (Pubitemid 20046127)
7. Schanbacher, F. L.; Goodman, R. E.; Talhouk, R. S.; Bovine mammary lactoferrin: Implications from messenger ribonucleic acid (mRNA) sequence and regulation contrary to other milk proteins. J. Dairy Sci., 1993, 76(12), 3812-31.
8. Grossmann, J. G.; Neu, M.; Pantos, E.; Schwab, F. J.; Evans, R. W.; Townes- Andrews, E.; Lindley, P. F.; Appel, H.; Thies, W. G.; Hasnain, S. S. X-ray solution scattering reveals conformational changes upon iron uptake in lactoferrin, serum and ovo-transferrins. J. Mol. Biol., 1992, 225(3), 811-9.
9. Brines, R. D.; Brock, J. H. The effect of trypsin and chymotrypsin on the in vitro antimicrobial and iron-binding properties of lactoferrin in human milk and bovine colostrum. Unusual resistance of human apolactoferrin to proteolytic digestion. Biochim. Biophys. Acta., 1983, 759(3), 229-35. (Pubitemid 13009058)
10. Brock, J. H.; Arzabe, F.; Lampreave, F.; Piñeiro, A. The effect of trypsin on bovine transferrin and lactoferrin. Biochim. Biophys. Acta., 1976, 446(1), 214-25.
11. Goodman, R. E.; Schanbacher, F. L. Bovine lactoferrin mRNA: Sequence, analysis, and expression in the mammary gland. Biochem. Biophys. Res. Commun., 1991, 180(1), 75-84.
12. Spik, G.; Strecker, G.; Fournet, B.; Bouquelet, S.; Montreuil, J.; Dorland, L.; van Halbeek, H.; Vliegenthart, J. F. Primary structure of the glycans from human lactotransferrin. Eur. J. Biochem., 1982, 121(2), 413-9. (Pubitemid 12178695)
13. van Berkel, P. H.; Welling, M. M.; Geerts, M.; van Veen, H. A.; Ravensbergen, B.; Salaheddine, M.; Pauwels, E. K.; Pieper, F.; Nuijens, J. H.; Nibbering, P. H. Large scale production of recombinant human lactoferrin in the milk of transgenic cows. Nat. Biotechnol., 2002, 20(5), 484-7. (Pubitemid 34495935)
14. Levay, P. F.; Viljoen, M. Lactoferrin: A general review. Haematologica, 1995, 80(3), 252-67.
15. Hurley, W. L.; Grieve, R. C.; Magura, C. E.; Hegarty, H. M.; Zou, S. Electrophoretic comparisons of lactoferrin from bovine mammary secretions, milk neutrophils, and human milk. J. Dairy Sci., 1993, 76(2), 377-87.
16. Fujiyama, K.; Sakai, Y.; Misaki, R.; Yanagihara, I.; Honda, T.; Anzai, H.; Seki, T. N-linked glycan structures of human lactoferrin produced by transgenic rice. Biosci. Biotechnol. Biochem., 2004, 68(12), 2565-70. (Pubitemid 40218187)
17. Samyn-Petit, B.; Wajda Dubos, J. P.; Chirat, F.; Coddeville, B.; Demaizieres, G.; Farrer, S.; Slomianny, M. C.; Theisen, M.; Delannoy, P. Comparative analysis of the site-specific N-glycosylation of human lactoferrin produced in maize and tobacco plants. Eur. J. Biochem., 2003, 270(15), 3235-42. (Pubitemid 36930189)
18. Samyn-Petit, B.; Gruber, V.; Flahaut, C.; Wajda-Dubos, J. P.; Farrer, S.; Pons, A.; Desmaizieres, G.; Slomianny, M. C.; Theisen, M.; Delannoy, P. Nglycosylation potential of maize: The human lactoferrin used as a model. Glycoconj. J., 2001, 18(7), 519-27.
19. Yu, T.; Guo, C.; Wang, J.; Hao, P.; Sui, S.; Chen, X.; Zhang, R.; Wang, P.; Yu, G.; Zhang, L.; Dai, Y.; Li, N. Comprehensive characterization of the site-specific N-glycosylation of wild-type and recombinant human lactoferrin expressed in milk of transgenic cloned cattle. Glycobiology, 2010.
20. Nandi, S.; Yalda, D.; Lu, S.; Nikolov, Z.; Misaki, R.; Fujiyama, K.; Huang, N. Process development and economic evaluation of recombinant human lactoferrin expressed in rice grain. Transgenic Res., 2005, 14(3), 237-49. (Pubitemid 40982710)
21. Brock, J. H. The physiology of lactoferrin. Biochem. Cell. Biol., 2002, 80(1), 1-6. (Pubitemid 34194221)
22. Weinberg, E. D. Iron loading: A risk factor for osteoporosis. Biometals, 2006, 19(6), 633-5. (Pubitemid 44691518)
23. Ward, P. P.; Paz, E.; Conneely, O. M. Multifunctional roles of lactoferrin: A critical overview. Cell. Mol. Life Sci., 2005, 62(22), 2540-8. (Pubitemid 41721229)
24. Ward, P. P.; Uribe-Luna, S.; Conneely, O. M. Lactoferrin and host defense. Biochem. Cell Biol., 2002, 80(1), 95-102. (Pubitemid 34194233)
25. Brock, J. Lactoferrin: A multifunctional immunoregulatory protein? Immunol. Today, 1995, 16(9), 417-9.
26. Baker, H. M.; Baker, E. N. Lactoferrin and iron: Structural and dynamic aspects of binding and release. Biometals, 2004, 17(3), 209-16. (Pubitemid 38987139)
27. Norrby, K. Human apo-lactoferrin enhances angiogenesis mediated by vascular endothelial growth factor A in vivo. J. Vasc. Res., 2004, 41(4), 293-304. (Pubitemid 39370272)
28. Baveye, S.; Elass, E.; Mazurier, J.; Spik, G.; Legrand, D. Lactoferrin: A multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin. Chem. Lab. Med., 1999, 37(3), 281-6. (Pubitemid 29209742)
29. Lee, S. H.; Pyo, C. W.; Hahm, D. H.; Kim, J.; Choi, S. Y. Iron-saturated lactoferrin stimulates cell cycle progression through PI3K/Akt pathway. Mol. Cells., 2009, 28(1), 37-42.
30. Cornish, J.; Palmano, K.; Callon, K. E.; Watson, M.; Lin, J. M.; Valenti, P.; Naot, D.; Grey, A. B.; Reid, I. R. Lactoferrin and bone; structure-activity relationships. Biochem. Cell. Biol., 2006, 84(3), 297-302. (Pubitemid 44341304)
31. Cornish, J.; Callon, K. E.; Naot, D.; Palmano, K. P.; Banovic, T.; Bava, U.; Watson, M.; Lin, J. M.; Tong, P. C.; Chen, Q.; Chan, V. A.; Reid, H. E.; Fazzalari, N.; Baker, H. M.; Baker, E. N.; Haggarty, N. W.; Grey, A. B.; Reid, I. R. Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology, 2004, 145(9), 4366-74. (Pubitemid 39120586)
32. Lorget, F.; Clough, J.; Oliveira, M.; Daury, M. C.; Sabokbar, A.; Offord, E. Lactoferrin reduces in vitro osteoclast differentiation and resorbing activity. Biochem. Biophys. Res. Commun., 2002, 296(2), 261-6.
33. Parfitt, A. M. The actions of parathyroid hormone on bone: Relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part IV of IV parts: The state of the bones in uremic hyperaparathyroidism- the mechanisms of skeletal resistance to PTH in renal failure and pseudohypoparathyroidism and the role of PTH in osteoporosis, osteopetrosis, and osteofluorosis. Metabolism, 1976, 25(10), 1157-88.
34. Cornish, J. Lactoferrin promotes bone growth. Biometals, 2004, 17(3), 331-5. (Pubitemid 38987158)
35. Ieni, A.; Barresi, V.; Grosso, M.; Rosa, M. A.; Tuccari, G. Lactoferrin immuno-expression in human normal and neoplastic bone tissue. J. Bone Miner. Metab., 2009, 27(3), 364-71.
36. Grey, A.; Banovic, T.; Zhu, Q.; Watson, M.; Callon, K.; Palmano, K.; Ross, J.; Naot, D.; Reid, I. R.; Cornish, J. The low-density lipoprotein receptorrelated protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells. Mol. Endocrinol., 2004, 18(9), 2268-78. (Pubitemid 39215255)
37. Naot, D.; Grey, A.; Reid, I. R.; Cornish, J. Lactoferrin-a novel bone growth factor. Clin. Med. Res., 2005, 3(2), 93-101.
38. Ji, Z. S.; Mahley, R. W. Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein. Further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG. Arterioscler. Thromb., 1994, 14(12), 2025-31.
39. Meilinger, M.; Haumer, M.; Szakmary, K. A.; Steinböck, F.; Scheiber, B.; Goldenberg, H.; Huettinger, M. Removal of lactoferrin from plasma is mediated by binding to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor and transport to endosomes. FEBS Lett., 1995, 360(1), 70-4.
40. Vash, B.; Phung, N.; Zein, S.; DeCamp, D. Three complement-type repeats of the low-density lipoprotein receptor-related protein define a common binding site for RAP, PAI-1, and lactoferrin. Blood, 1998, 92(9), 3277-85. (Pubitemid 28492335)
41. Willnow, T. E.; Goldstein, J. L.; Orth, K.; Brown, M. S.; Herz, J. Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J. Biol. Chem., 1992, 267(36), 26172-80. (Pubitemid 23014032)
42. Herz, J.; Gotthardt, M.; Willnow, T. E. Cellular signalling by lipoprotein receptors. Curr. Opin. Lipidol., 2000, 11(2), 161-6. (Pubitemid 30219111)
43. Neels, J. G.; van Den Berg, B. M.; Lookene, A.; Olivecrona, G.; Pannekoek, H.; van Zonneveld, A. J. The second and fourth cluster of class A cysteinerich repeats of the low density lipoprotein receptor-related protein share ligand-binding properties. J. Biol. Chem., 1999, 274(44), 31305-11.
44. Li, Y.; Cam, J.; Bu, G. Low-density lipoprotein receptor family: Endocytosis and signal transduction. Mol. Neurobiol., 2001, 23(1), 53-67. (Pubitemid 32948272)
45. Strickland, D. K.; Gonias, S. L.; Argraves, W. S. Diverse roles for the LDL receptor family. Trends Endocrinol. Metab., 2002, 13(2), 66-74. (Pubitemid 36740449)
46. Niemeier, A.; Kassem, M.; Toedter, K.; Wendt, D.; Ruether, W.; Beisiegel, U.; Heeren, J. Expression of LRP1 by human osteoblasts: A mechanism for the delivery of lipoproteins and vitamin K1 to bone. J. Bone Miner. Res., 2005, 20(2), 283-93.
47. Gong, Y.; Slee, R. B.; Fukai, N.; Rawadi, G.; Roman-Roman, S.; Reginato, A. M.; Wang, H.; Cundy, T.; Glorieux, F. H.; Lev, D.; Zacharin, M.; Oexle, K.; Marcelino, J.; Suwairi, W.; Heeger, S.; Sabatakos, G.; Apte, S.; Adkins, W. N.; Allgrove, J.; Arslan-Kirchner, M.; Batch, J. A.; Beighton, P.; Black, G. C.; Boles, R. G.; Boon, L. M.; Borrone, C.; Brunner, H. G.; Carle, G. F.; Dallapiccola, B.; De Paepe, A.; Floege, B.; Halfhide, M. L.; Hall, B.; Hennekam, R. C.; Hirose, T.; Jans, A.; Jüppner, H.; Kim, C. A.; Keppler- Noreuil, K.; Kohlschuetter, A.; LaCombe, D.; Lambert, M.; Lemyre, E.; Letteboer, T.; Peltonen, L.; Ramesar, R. S.; Romanengo, M.; Somer, H.; Steichen-Gersdorf, E.; Steinmann, B.; Sullivan, B.; Superti-Furga, A.; Swoboda, W.; van den Boogaard, M. J.; Van Hul, W.; Vikkula, M.; Votruba, M.; Zabel, B.; Garcia, T.; Baron, R.; Olsen, B. R.; Warman, M. L.; Group, O.-P. S. C. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell, 2001, 107(4), 513-23. (Pubitemid 33152786)
48. Babij, P.; Zhao, W.; Small, C.; Kharode, Y.; Yaworsky, P. J.; Bouxsein, M. L.; Reddy, P. S.; Bodine, P. V.; Robinson, J. A.; Bhat, B.; Marzolf, J.; Moran, R. A.; Bex, F. High bone mass in mice expressing a mutant LRP5 gene. J. Bone Miner. Res., 2003, 18(6), 960-74. (Pubitemid 37294932)
49. Tamai, K.; Semenov, M.; Kato, Y.; Spokony, R.; Liu, C.; Katsuyama, Y.; Hess, F.; Saint-Jeannet, J. P.; He, X. LDL-receptor-related proteins in Wnt signal transduction. Nature, 2000, 407(6803), 530-5.
50. Zilberberg, A.; Yaniv, A.; Gazit, A. The low density lipoprotein receptor-1, LRP1, interacts with the human frizzled-1 (HFz1) and down-regulates the canonical Wnt signaling pathway. J. Biol. Chem., 2004, 279(17), 17535-42. (Pubitemid 38560517)
51. Howell, B. W.; Herz, J. The LDL receptor gene family: Signaling functions during development. Curr. Opin. Neurobiol., 2001, 11(1), 74-81. (Pubitemid 32155952)
52. Cornish, J.; Naot, D. Lactoferrin as an effector molecule in the skeleton. Biometals, 2010, 23(3), 425-30.
53. Grey, A.; Zhu, Q.; Watson, M.; Callon, K.; Cornish, J. Lactoferrin potently inhibits osteoblast apoptosis, via an LRP1-independent pathway. Mol. Cell. Endocrinol., 2006, 251(1-2), 96-102. (Pubitemid 43728834)
54. Orr, A. W.; Pedraza, C. E.; Pallero, M. A.; Elzie, C. A.; Goicoechea, S.; Strickland, D. K.; Murphy-Ullrich, J. E. Low density lipoprotein receptorrelated protein is a calreticulin coreceptor that signals focal adhesion disassembly. J. Cell. Biol., 2003, 161(6), 1179-89. (Pubitemid 36870178)
55. Elass-Rochard, E.; Roseanu, A.; Legrand, D.; Trif, M.; Salmon, V.; Motas, C.; Montreuil, J.; Spik, G. Lactoferrin-lipopolysaccharide interaction: Involvement of the 28-34 loop region of human lactoferrin in the high affinity binding to Escherichia coli 055B5 lipopolysaccharide. Biochem. J., 1995, 312(3), 839-45. (Pubitemid 26005997)
56. Appelmelk, B. J.; An, Y. Q.; Geerts, M.; Thijs, B. G.; de Boer, H. A.; MacLaren, D. M.; de Graaff, J.; Nuijens, J. H. Lactoferrin is a lipid Abinding protein. Infect. Immun., 1994, 62(6), 2628-32.
57. Shimazaki, K.; Tazume, T.; Uji, K.; Tanaka, M.; Kumura, H.; Mikawa, K.; Shimo-Oka, T. Properties of a heparin-binding peptide derived from bovine lactoferrin. J. Dairy Sci., 1998, 81(11), 2841-9. (Pubitemid 128447781)
58. Mann, D. M.; Romm, E.; Migliorini, M. Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin. J. Biol. Chem., 1994, 269(38), 23661-7. (Pubitemid 24293571)
59. Hutchens, T. W.; Magnuson, J. S.; Yip, T. T. Interaction of human lactoferrin with DNA: One-step purification by affinity chromatography on single-stranded DNA-agarose. Pediatr. Res., 1989, 26(6), 618-22. (Pubitemid 20001671)
60. Grey, A.; Chen, Q.; Xu, X.; Callon, K.; Cornish, J. Parallel phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways subserve the mitogenic and antiapoptotic actions of insulin-like growth factor I in osteoblastic cells. Endocrinology, 2003, 144(11), 4886-93. (Pubitemid 37378403)
61. Baumrucker, C. R.; Gibson, C. A.; Schanbacher, F. L. Bovine lactoferrin binds to insulin-like growth factor-binding protein-3. Domest. Anim. Endocrinol., 2003, 24(4), 287-303. (Pubitemid 36639689)
62. Legrand, D.; Elass, E.; Carpentier, M.; Mazurier, J. Lactoferrin: A modulator of immune and inflammatory responses. Cell. Mol. Life Sci., 2005, 62(22), 2549-59. (Pubitemid 41722207)
63. Spadaro, M.; Caorsi, C.; Ceruti, P.; Varadhachary, A.; Forni, G.; Pericle, F.; Giovarelli, M. Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells. FASEB J., 2008, 22(8), 2747-57.
64. van Hooijdonk, A. C.; Kussendrager, K. D.; Steijns, J. M. In vivo antimicrobial and antiviral activity of components in bovine milk and colostrum involved in non-specific defence. Br. J. Nutr., 2000, 84 Suppl 1, S127-34. (Pubitemid 32106838)
65. Breton-Gorius, J.; Mason, D. Y.; Buriot, D.; Vilde, J. L.; Griscelli, C. Lactoferrin deficiency as a consequence of a lack of specific granules in neutrophils from a patient with recurrent infections. Detection by immunoperoxidase staining for lactoferrin and cytochemical electron microscopy. Am. J. Pathol., 1980, 99(2), 413-28. (Pubitemid 10116234)
66. Guillén, C.; McInnes, I. B.; Vaughan, D. M.; Kommajosyula, S.; Van Berkel, P. H.; Leung, B. P.; Aguila, A.; Brock, J. H. Enhanced Th1 response to Staphylococcus aureus infection in human lactoferrin-transgenic mice. J. Immunol., 2002, 168(8), 3950-7. (Pubitemid 34298399)
67. Lee, W. J.; Farmer, J. L.; Hilty, M.; Kim, Y. B. The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets. Infect. Immun., 1998, 66(4), 1421-6. (Pubitemid 128471499)
68. Zagulski, T.; Lipiński, P.; Zagulska, A.; Broniek, S.; Jarzabek, Z. Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo. Br. J. Exp. Pathol., 1989, 70(6), 697-704. (Pubitemid 20022137)
69. Byrd, T. F.; Horwitz, M. A. Lactoferrin inhibits or promotes Legionella pneumophila intracellular multiplication in nonactivated and interferon gamma-activated human monocytes depending upon its degree of iron saturation. Iron-lactoferrin and nonphysiologic iron chelates reverse monocyte activation against Legionella pneumophila. J. Clin. Invest., 1991, 88(4), 1103-12.
70. Bennett, R. M.; Davis, J. Lactoferrin binding to human peripheral blood cells: An interaction with a B-enriched population of lymphocytes and a subpopulation of adherent mononuclear cells. J. Immunol., 1981, 127(3), 1211-6. (Pubitemid 11051189)
71. Birgens, H. S.; Hansen, N. E.; Karle, H.; Kristensen, L. O. Receptor binding of lactoferrin by human monocytes. Br. J. Haematol., 1983, 54(3), 383-91. (Pubitemid 13054560)
72. Campbell, T.; Skilton, R. A.; Coombes, R. C.; Shousha, S.; Graham, M. D.; Luqmani, Y. A. Isolation of a lactoferrin cDNA clone and its expression in human breast cancer. Br. J. Cancer, 1992, 65(1), 19-26.
73. Håversen, L.; Ohlsson, B. G.; Hahn-Zoric, M.; Hanson, L. A.; Mattsby- Baltzer, I. Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappa B. Cell. Immunol., 2002, 220(2), 83-95. (Pubitemid 36349060)
74. Lauw, F. N.; Pajkrt, D.; Hack, C. E.; Kurimoto, M.; van Deventer, S. J.; van der Poll, T. Proinflammatory effects of IL-10 during human endotoxemia. J. Immunol., 2000, 165(5), 2783-9. (Pubitemid 30660729)
75. Shimizu, K.; Matsuzawa, H.; Okada, K.; Tazume, S.; Dosako, S.; Kawasaki, Y.; Hashimoto, K.; Koga, Y. Lactoferrin-mediated protection of the host from murine cytomegalovirus infection by a T-cell-dependent augmentation of natural killer cell activity. Arch. Virol., 1996, 141(10), 1875-89. (Pubitemid 26392962)
76. Yamauchi, K.; Wakabayashi, H.; Hashimoto, S.; Teraguchi, S.; Hayasawa, H.; Tomita, M. Effects of orally administered bovine lactoferrin on the immune system of healthy volunteers. Adv. Exp. Med. Biol., 1998, 443, 261-5.
77. Szuster-Ciesielska, A.; Kamińska, T.; Kandefer-Szerszeń, M. Phagocytosisenhancing effect of lactoferrin on bovine peripheral blood monocytes in vitro and in vivo. Arch. Vet. Pol., 1995, 35(1-2), 63-71.
78. Wakabayashi, H.; Takakura, N.; Teraguchi, S.; Tamura, Y. Lactoferrin feeding augments peritoneal macrophage activities in mice intraperitoneally injected with inactivated Candida albicans. Microbiol. Immunol., 2003, 47(1), 37-43. (Pubitemid 36119649)
79. Damiens, E.; Mazurier, J.; el Yazidi, I.; Masson, M.; Duthille, I.; Spik, G.; Boilly-Marer, Y. Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells. Biochim. Biophys. Acta., 1998, 1402(3), 277-87. (Pubitemid 28206922)
80. Miyauchi, H.; Hashimoto, S.; Nakajima, M.; Shinoda, I.; Fukuwatari, Y.; Hayasawa, H. Bovine lactoferrin stimulates the phagocytic activity of human neutrophils: Identification of its active domain. Cell. Immunol., 1998, 187(1), 34-7. (Pubitemid 28359692)
81. Zimecki, M.; Kocieba, M.; Kruzel, M. Immunoregulatory activities of lactoferrin in the delayed type hypersensitivity in mice are mediated by a receptor with affinity to mannose. Immunobiology, 2002, 205(1), 120-31. (Pubitemid 34285411)
82. Actor, J. K.; Hwang, S. A.; Olsen, M.; Zimecki, M.; Hunter, R. L.; Kruzel, M. L. Lactoferrin immunomodulation of DTH response in mice. Int. Immunopharmacol., 2002, 2(4), 475-86. (Pubitemid 34169743)
83. Sorimachi, K.; Akimoto, K.; Hattori, Y.; Ieiri, T.; Niwa, A. Activation of macrophages by lactoferrin: Secretion of TNF-alpha, IL-8 and NO. Biochem. Mol. Biol. Int., 1997, 43(1), 79-87. (Pubitemid 28297194)
84. Zimecki, M.; Machnicki, M. Lactoferrin inhibits the effector phase of the delayed type hypersensitivity to sheep erythrocytes and inflammatory reactions to M. bovis (BCG). Arch. Immunol. Ther. Exp., 1994, 42(3), 171-7.
85. Sawatzki, G.; Rich, I. N. Lactoferrin stimulates colony stimulating factor production in vitro and in vivo. Blood Cells, 1989, 15(2), 371-85. (Pubitemid 19147925)
86. Broxmeyer, H. E.; Williams, D. E.; Hangoc, G.; Cooper, S.; Gentile, P.; Shen, R. N.; Ralph, P.; Gillis, S.; Bicknell, D. C. The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors. Blood Cells, 1987, 13(1-2), 31-48. (Pubitemid 17124375)
87. Machnicki, M.; Zimecki, M.; Zagulski, T. Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo. Int. J. Exp. Pathol., 1993, 74(5), 433-9. (Pubitemid 23304079)
88. Kruzel, M. L.; Harari, Y.; Mailman, D.; Actor, J. K.; Zimecki, M. Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice. Clin. Exp. Immunol., 2002, 130(1), 25-31.
89. Togawa, J.; Nagase, H.; Tanaka, K.; Inamori, M.; Nakajima, A.; Ueno, N.; Saito, T.; Sekihara, H. Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. J. Gastroenterol. Hepatol., 2002, 17(12), 1291-8. (Pubitemid 35356966)
90. Miyazawa, K.; Mantel, C.; Lu, L.; Morrison, D. C.; Broxmeyer, H. E. Lactoferrin-lipopolysaccharide interactions. Effect on lactoferrin binding to monocyte/macrophage-differentiated HL-60 cells. J. Immunol., 1991, 146(2), 723-9.
91. Britigan, B. E.; Lewis, T. S.; Waldschmidt, M.; McCormick, M. L.; Krieg, A. M. Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells. J. Immunol., 2001, 167(5), 2921-8. (Pubitemid 32768927)
92. Elass-Rochard, E.; Legrand, D.; Salmon, V.; Roseanu, A.; Trif, M.; Tobias, P. S.; Mazurier, J.; Spik, G. Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein. Infect. Immun., 1998, 66(2), 486-91. (Pubitemid 28074186)
93. Baveye, S.; Elass, E.; Mazurier, J.; Legrand, D. Lactoferrin inhibits the binding of lipopolysaccharides to L-selectin and subsequent production of reactive oxygen species by neutrophils. FEBS Lett., 2000, 469(1), 5-8. (Pubitemid 30119858)
94. Baveye, S.; Elass, E.; Fernig, D. G.; Blanquart, C.; Mazurier, J.; Legrand, D. Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex. Infect. Immun., 2000, 68(12), 6519-25. (Pubitemid 32463349)
95. Curran, C. S.; Demick, K. P.; Mansfield, J. M. Lactoferrin activates macrophages via TLR4-dependent and -independent signaling pathways. Cell. Immunol., 2006, 242(1), 23-30. (Pubitemid 44894393)
96. Elrod, K. C.; Moore, W. R.; Abraham, W. M.; Tanaka, R. D. Lactoferrin, a potent tryptase inhibitor, abolishes late-phase airway responses in allergic sheep. Am. J. Respir. Crit. Care Med., 1997, 156(2 Pt 1), 375-81. (Pubitemid 27351967)
97. Griffiths, C. E.; Cumberbatch, M.; Tucker, S. C.; Dearman, R. J.; Andrew, S.; Headon, D. R.; Kimber, I. Exogenous topical lactoferrin inhibits allergeninduced Langerhans cell migration and cutaneous inflammation in humans. Br. J. Dermatol., 2001, 144(4), 715-25. (Pubitemid 32374772)
98. Zweiman, B.; Kucich, U.; Shalit, M.; Von Allmen, C.; Moskovitz, A.; Weinbaum, G.; Atkins, P. C. Release of lactoferrin and elastase in human allergic skin reactions. J. Immunol., 1990, 144(10), 3953-60. (Pubitemid 20171210)
99. Kimber, I.; Cumberbatch, M.; Dearman, R. J.; Headon, D. R.; Bhushan, M.; Griffiths, C. E. Lactoferrin: Influences on Langerhans cells, epidermal cytokines, and cutaneous inflammation. Biochem. Cell. Biol., 2002, 80(1), 103-7. (Pubitemid 34194234)
100. Kruzel, M. L. Role of lactoferrin in development of inflammation. Postepy. Hig. Med. Dosw., 2003, 57(4), 377-404.
101. Dwek, R. A. Glycobiology: "towards understanding the function of sugars". Biochem. Soc. Trans., 1995, 23(1), 1-25.
102. Walsh, G.; Jefferis, R. Post-translational modifications in the context of therapeutic proteins. Nat. Biotechnol., 2006, 24(10), 1241-52. (Pubitemid 44564769)
103. Choi, B. K.; Actor, J. K.; Rios, S.; d'Anjou, M.; Stadheim, T. A.; Warburton, S.; Giaccone, E.; Cukan, M.; Li, H.; Kull, A.; Sharkey, N.; Gollnick, P.; Kocieba, M.; Artym, J.; Zimecki, M.; Kruzel, M. L.; Wildt, S. Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris: Effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune response. Glycoconj. J., 2008, 25(6), 581-93.
104. Engelmayer, J.; Blezinger, P.; Varadhachary, A. Talactoferrin stimulates wound healing with modulation of inflammation. J. Surg. Res., 2008, 149(2), 278-86.
105. de la Rosa, G.; Yang, D.; Tewary, P.; Varadhachary, A.; Oppenheim, J. J. Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses. J. Immunol., 2008, 180(10), 6868-76.
106. Varadhachary, A.; Wolf, J. S.; Petrak, K.; O'Malley, B. W.; Spadaro, M.; Curcio, C.; Forni, G.; Pericle, F. Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy. Int. J. Cancer, 2004, 111(3), 398-403. (Pubitemid 38998820)
107. Wolf, J. S.; Li, G.; Varadhachary, A.; Petrak, K.; Schneyer, M.; Li, D.; Ongkasuwan, J.; Zhang, X.; Taylor, R. J.; Strome, S. E.; O'Malley, B. W. Oral lactoferrin results in T cell-dependent tumor inhibition of head and neck squamous cell carcinoma in vivo. Clin. Cancer Res., 2007, 13(5), 1601-10. (Pubitemid 46450453)
108. Hayes, T. G.; Falchook, G. F.; Varadhachary, G. R.; Smith, D. P.; Davis, L. D.; Dhingra, H. M.; Hayes, B. P.; Varadhachary, A. Phase I trial of oral talactoferrin alfa in refractory solid tumors. Invest. New Drugs, 2006, 24(3), 233-40. (Pubitemid 43723899)
109. Puddu, P.; Valenti, P.; Gessani, S. Immunomodulatory effects of lactoferrin on antigen presenting cells. Biochimie, 2009, 91(1), 11-8.
110. Takayanagi, H. Mechanistic insight into osteoclast differentiation in osteoimmunology. J. Mol. Med., 2005, 83(3), 170-9. (Pubitemid 40487405)
111. Yoshida, H.; Hayashi, S.; Kunisada, T.; Ogawa, M.; Nishikawa, S.; Okamura, H.; Sudo, T.; Shultz, L. D. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature, 1990, 345(6274), 442-4. (Pubitemid 120014957)
112. Blais, A.; Malet, A.; Mikogami, T.; Martin-Rouas, C.; Tomé, D. Oral bovine lactoferrin improves bone status of ovariectomized mice. Am. J. Physiol. Endocrinol. Metab., 2009, 296(6), E1281-8.
113. Fox, S. W.; Fuller, K.; Chambers, T. J. Activation of osteoclasts by interleukin-1: Divergent responsiveness in osteoclasts formed in vivo and in vitro. J. Cell. Physiol., 2000, 184(3), 334-40. (Pubitemid 30625496)
114. Fuller, K.; Murphy, C.; Kirstein, B.; Fox, S. W.; Chambers, T. J. TNFalpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology, 2002, 143(3), 1108-18. (Pubitemid 34164059)
115. Kudo, O.; Fujikawa, Y.; Itonaga, I.; Sabokbar, A.; Torisu, T.; Athanasou, N. A. Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation. J. Pathol., 2002, 198(2), 220-7. (Pubitemid 35243880)
116. Zhao, Q.; Wang, X.; Liu, Y.; He, A.; Jia, R. NFATc1: Functions in osteoclasts. Int. J. Biochem. Cell. Biol., 2010, 42(5), 576-9.
117. Stern, P. H. The calcineurin-NFAT pathway and bone: Intriguing new findings. Mol. Interv., 2006, 6(4), 193-6. (Pubitemid 44455200)
118. Winslow, M. M.; Pan, M.; Starbuck, M.; Gallo, E. M.; Deng, L.; Karsenty, G.; Crabtree, G. R. Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Dev. Cell., 2006, 10(6), 771-82. (Pubitemid 43779111)
119. Yamano, E.; Miyauchi, M.; Furusyo, H.; Kawazoe, A.; Ishikado, A.; Makino, T.; Tanne, K.; Tanaka, E.; Takata, T. Inhibitory effects of orally administrated liposomal bovine lactoferrin on the LPS-induced osteoclastogenesis. Lab. Invest., 2010, 90(8), 1236-46.
120. Clowes, J. A.; Riggs, B. L.; Khosla, S. The role of the immune system in the pathophysiology of osteoporosis. Immunol. Rev., 2005, 208, 207-27. (Pubitemid 41746395)
121. Weitzmann, M. N.; Pacifici, R. T cells: Unexpected players in the bone loss induced by estrogen deficiency and in basal bone homeostasis. Ann. N. Y. Acad. Sci., 2007, 1116, 360-75. (Pubitemid 350274346)
122. Eberhard, J.; Drosos, Z.; Tiemann, M.; Jepsen, S.; Schröder, J. M. Immunolocalization of lactoferrin in healthy and inflamed gingival tissues. J. Periodontol., 2006, 77(3), 472-8. (Pubitemid 44740671)
123. Nicholson, G. C.; Malakellis, M.; Collier, F. M.; Cameron, P. U.; Holloway, W. R.; Gough, T. J.; Gregorio-King, C.; Kirkland, M. A.; Myers, D. E. Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor kappaB ligand (RANKL). Clin. Sci. (Lond.), 2000, 99(2), 133-40. (Pubitemid 30614381)
124. Mäkelä, M.; Salo, T.; Uitto, V. J.; Larjava, H. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: Cellular origin and relationship to periodontal status. J. Dent. Res., 1994, 73(8), 1397-406.
125. Nakayama, K.; Otsuki, K.; Yakuwa, K.; Hasegawa, A.; Sawada, M.; Mitsukawa, K.; Chiba, H.; Nagatsuka, M.; Okai, T. Recombinant human lactoferrin inhibits matrix metalloproteinase (MMP-2, MMP-3, and MMP-9) activity in a rabbit preterm delivery model. J. Obstet. Gynaecol. Res., 2008, 34(6), 931-4.
126. Toba, Y.; Takada, Y.; Yamamura, J.; Tanaka, M.; Matsuoka, Y.; Kawakami, H.; Itabashi, A.; Aoe, S.; Kumegawa, M. Milk basic protein: A novel protective function of milk against osteoporosis. Bone, 2000, 27(3), 403-8. (Pubitemid 30658124)
127. Morita, Y.; Matsuyama, H.; Serizawa, A.; Takeya, T.; Kawakami, H. Identification of angiogenin as the osteoclastic bone resorption-inhibitory factor in bovine milk. Bone, 2008, 42(2), 380-7.
128. Bharadwaj, S.; Naidu, A. G.; Betageri, G. V.; Prasadarao, N. V.; Naidu, A. S. Milk ribonuclease-enriched lactoferrin induces positive effects on bone turnover markers in postmenopausal women. Osteoporos. Int., 2009, 20(9), 1603-11.
129. Schaper, W.; Ito, W. D. Molecular mechanisms of coronary collateral vessel growth. Circ. Res., 1996, 79(5), 911-9. (Pubitemid 26359232)
130. Isner, J. M.; Asahara, T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J. Clin. Invest., 1999, 103(9), 1231-6. (Pubitemid 29218292)
131. Norrby, K.; Mattsby-Baltzer, I.; Innocenti, M.; Tuneberg, S. Orally administered bovine lactoferrin systemically inhibits VEGF(165)-mediated angiogenesis in the rat. Int. J. Cancer, 2001, 91(2), 236-40. (Pubitemid 32041746)
132. Shimamura, M.; Yamamoto, Y.; Ashino, H.; Oikawa, T.; Hazato, T.; Tsuda, H.; Iigo, M. Bovine lactoferrin inhibits tumor-induced angiogenesis. Int. J. Cancer, 2004, 111(1), 111-6. (Pubitemid 38859291)
133. Mader, J. S.; Smyth, D.; Marshall, J.; Hoskin, D. W. Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells. Am. J. Pathol., 2006, 169(5), 1753-66. (Pubitemid 351182006)
134. Kim, C. W.; Son, K. N.; Choi, S. Y.; Kim, J. Human lactoferrin upregulates expression of KDR/Flk-1 and stimulates VEGF-A-mediated endothelial cell proliferation and migration. FEBS Lett., 2006, 580(18), 4332-6. (Pubitemid 44118249)
135. Tsujii, M.; Kawano, S.; Tsuji, S.; Sawaoka, H.; Hori, M.; DuBois, R. N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 1998, 93(5), 705-16. (Pubitemid 28257578)
136. Yagi, M.; Suzuki, N.; Takayama, T.; Arisue, M.; Kodama, T.; Yoda, Y.; Otsuka, K.; Ito, K. Effects of lactoferrin on the differentiation of pluripotent mesenchymal cells. Cell. Biol. Int., 2009, 33(3), 283-9.
137. Huang, N.; Bethell, D.; Card, C.; Cornish, J.; Marchbank, T.; Wyatt, D.; Mabery, K.; Playford, R. Bioactive recombinant human lactoferrin, derived from rice, stimulates mammalian cell growth. In Vitro Cell Dev. Biol. Anim., 2008, 44(10), 464-71.
138. Lyons, T. E.; Miller, M. S.; Serena, T.; Sheehan, P.; Lavery, L.; Kirsner, R. S.; Armstrong, D. G.; Reese, A.; Yankee, E. W.; Veves, A. Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: A phase 1/2 clinical study. Am. J. Surg., 2007, 193(1), 49-54. (Pubitemid 44937166)
139. Jonasch, E.; Stadler, W. M.; Bukowski, R. M.; Hayes, T. G.; Varadhachary, A.; Malik, R.; Figlin, R. A.; Srinivas, S. Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma. Cancer, 2008, 113(1), 72-7. (Pubitemid 351976388)
140. Takayama, Y.; Mizumachi, K. Effect of lactoferrin-embedded collagen membrane on osteogenic differentiation of human osteoblast-like cells. J. Biosci. Bioeng., 2009, 107(2), 191-5.
141. Takaoka, R.; Hikasa, Y.; Hayashi, K.; Tabata, Y. Bone regeneration by lactoferrin released from a gelatin hydrogel. J. Biomater. Sci. Polym. Ed., 2010.